Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2024 | 2025 | |
|---|---|---|---|
| Revenue | $0 | $43.1M | $130.0M |
| Cost of revenue | $0 | $20.6M | $77.5M |
| Gross profit | $0 | $22.5M | $52.5M |
| Gross margin | — | 52.2% | 40.4% |
| R&D | $0 | $136.8M | $305.7M |
| Operating income | −$659.8K | −$232.5M | −$633.7M |
| EBITDA | −$629.3K | −$313.1M | $82.0M |
| Net income | −$629.3K | −$331.6M | −$510.4M |
| Net margin | — | -770.0% | -392.6% |
| EPS (diluted) | -0.02 | -1.56 | -1.82 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds DMYI.
No tracked institution reports a position in DMYI as of their last filing.
No one on the platform has traded DMYI yet.
| +0.10% |
| $2.0B |
| — |
| NVTSNavitas Semiconductor Corp | $17.74 | +2.54% | $4.3B | — |
| PROKProKidney Corp. | $1.89 | +3.28% | $636M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.